— Know what they know.
Not Investment Advice
Also trades as: HUMAW (NASDAQ) · $vol 0M

HUMA NASDAQ

Humacyte, Inc.
1W: -6.4% 1M: -12.6% 3M: -32.3% YTD: -46.5% 1Y: -70.4% 3Y: -82.4% 5Y: -95.8%
$0.52
+0.02 (+3.70%)
 
Weekly Expected Move ±4.7%
$0 $0 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 30 · $87.6M mcap · 138M float · 6.67% daily turnover · Short 59% of daily vol

📊 Key Metrics

TTM
$2M
Revenue
-73.6% YoY
$-97M
Net Income
-64.9% YoY
$-98M
Free Cash Flow
+8.2% YoY
-203.2%
Gross Margin
-6649.3%
Op. Margin
-9064.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-547.9%
ROA-69.9%
ROIC-500.7%

Valuation

P/E-1.0
P/B3.9
EV/EBITDA-2.1

Leverage

Debt/Equity2.12
Current Ratio6.21
Interest Cov.-8.4x

Quality Scores

Piotroski F3/9
Altman Z-8.27
Beneish M-1.86

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms